Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Press Statements

      SkyCell and AirBridgeCargo expand partnership for passive pharma solutions services in airfreight

      Packaging & Logistic
      AirBridgeCargo Airlines (ABC) and SkyCell have sealed a close partnership for the lease of all types of SkyCell’s temperaturecontrolled containers. Russian all-cargo airline ABC...

      DHL invests $150M to expand pharma, medical supply chain

      Manufacturing
      Dive Brief: DHL Supply Chain plans to invest $150 million to expand its distribution network of medical devices and pharmaceutical supplies by 40%, the company...

      Boehringer Ingelheim Gubra to develop anti-obesity peptide poly agonists

      Drug Development
      Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity. It will bring together...

      Lantheus, NanoMab to offer novel biomarker to develop immuno-oncology therapies

      Drug Development
      Lantheus Holdings has collaborated with NanoMab Technology to provide a novel biomarker for clinical development and management of immuno-oncology therapies. As part of strategic collaboration...

      Samsung BioLogics Enters New Era with First-of-its-kind Client-Centric CMO Deal

      Manufacturing
      Samsung BioLogics (SBL) recently entered a new era by signing a "first of its kind" deal with a US bio-pharmaceutical company valued at $7.8...

      GSK joins forces with the University of California to advance genomic research and improve drug discovery

      Manufacturing
      GlaxoSmithKline plc announced a five-year collaboration with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research...

      Savara Announces Results of IMPALA a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)

      Manufacturing
      Savara Inc. , an orphan lung disease company announced top line data from IMPALA, a pivotal Phase 3 clinical study evaluating Molgradex, an inhaled...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.